What did Blue Wolf Capital Partners pay for CIVCO Radiotherapy?

Blue Wolf Capital Partners acquired CIVCO Radiotherapy for $120.0M in 2021, equivalent to 8.00x revenue. Target revenue was approximately $15.0M.

What does CIVCO Radiotherapy do?

CIVCO Radiotherapy is a medical devices business.

What multiple did Blue Wolf Capital Partners pay for CIVCO Radiotherapy?

8.00x revenue, based on disclosed deal value of $120.0M and disclosed financials.

M&A TRANSACTION · 2021

CIVCO Radiotherapy acquired by Blue Wolf Capital Partners

$120.0M· 8.00x revenue

Target

CIVCO Radiotherapy

Acquirer

Blue Wolf Capital Partners

Private Equity buyer

Disclosed financials at time of acquisition

Revenue

$15.0M

EBITDA

—

Deal Value

$120.0M

EV/EBITDA

—

Context

This $120.0M acquisition of CIVCO Radiotherapy by Blue Wolf Capital Partners sits in the medical devices sub-vertical. Blue Wolf Capital Partners is acquiring as a private equity buyer; see how PE acquirers typically price medical devices businesses on our Medical Devices PE buyer-pool page.

Source

Data sourced from Press releases. All figures reflect disclosed values at the time of the acquisition; no estimated or imputed data. Methodology

Value your own medical devices

Get an instant valuation range for your business. Backed by 25,592 real M&A transactions.

Compare your business to the CIVCO Radiotherapy acquisition.

Citation: ExitValue.ai. (2021). CIVCO Radiotherapy acquired by Blue Wolf Capital Partners. https://exitvalue.ai/deals/civco-radiotherapy-acquired-by-blue-wolf-capital-partners-hc-2021-0083